Abiopharma

Axsome Therapeutics Champions Brain Health During Alzheimers & Brain Awareness Month

New Form 8-K - AN2 Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143187 Size: 257 KB Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088165 Size: 5 KB

New Form 8-K - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088168 Size: 220 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088166 Size: 5 KB

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088164 Size: 5 KB

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088167 Size: 5 KB

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088162 Size: 5 KB

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088163 Size: 5 KB

Axsome Therapeutics Champions Brain Health During Alzheimers & Brain Awareness Month

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

New Form 6-K - Haleon plc Filed: 2025-06-20 AccNo: 0001654954-25-007209 Size: 34 KB

Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors

New Form IRANNOTICE - Medtronic plc Filed: 2025-06-20 AccNo: 0001613103-25-000092 Size: 6 KB

New Form 10-K - Medtronic plc Filed: 2025-06-20 AccNo: 0001613103-25-000091 Size: 24 MB